Jonathan Gillis sold $1.3M of MapLight Therapeutics (MPLT)

Executed Jul 15, disclosed Jul 20, 5 days later, against a two-business-day limit.

Value, as filed

$1.3M

34,003 sh across 4 lots

Executed

Jul 15

the trade date, as filed

Disclosed

Jul 20

5 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jonathan Gillis CAO and Interim CFO profile →

Jonathan Gillis (CAO and Interim CFO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales, 1 filed past the two-business-day deadline), most often in MapLight Therapeutics, Inc. (MPLT). The largest single filing was $2.1M of MPLT (69,135 sh across 4 lots, as filed), executed Apr 27.

The name

MPLT

MapLight Therapeutics, Inc. MPLT · Healthcare · 30 filings in 24 months ticker →

Healthcare · MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jonathan Gillis in MPLT

MPLTSALE MapLight Therapeutics, Inc. $2.1M
69,135 sh across 4 lots
Exec Apr 27
Filed Apr 29 · 5:30 PM ET